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INTRODUCTION
Mycobacterium tuberculosis infections can be associated with
several immune mechanisms. Some of these mechanisms, such
as vasculitis associated with tuberculosis, are rare and can
challenge dermatologists when making differential diagnoses.
The association between pulmonary tuberculosis (Tb) and
vasculitis was first described by Parish and Rhodes (1) in 1967.
These associations fall into three main types: pulmonary Tb/
cutaneous leukocytoclastic vasculitis (CLV), pulmonary Tb/
Henoch-Scho¨nlein purpura (HSP) and pulmonary Tb/vasculi-
tis secondary to rifampicin (2-7). The existence of circulating
immune complexes in pulmonary Tb has been demonstrated,
and the levels of these complexes are related to disease activity.
The mechanism of vascular damage is attributed to immune
complexes rather than to direct damage caused by M.
tuberculosis (8,9). Another differential diagnosis is CLV due to
rifampicin therapy (7). In cases of Tb-related vasculitis, skin
lesions usually improve following the administration of a
specific Tb treatment; an anti-inflammatory therapy is not
required (2-5,10). Immune complexes are also responsible for
renal injury, which is associated with increased levels of
immunoglobulins (mainly IgA against the A-60 antigen of M.
tuberculosis), and mesangial deposition, which leads to the
activation of the alternative complement and lecithin pathways,
resulting in glomerular damage (IgA nephropathy) (11). Finally,
Tb is associated with the development of anti-phospholipid
antibody syndrome (APS) by inducing the production of auto-
antibodies (18,19). The association of tuberculous lymphadeni-
tis, CLV, IgA nephropathy and APS in a single patient has not
been reported yet.
CASE DESCRIPTION
A 45-year-old woman from Ribeira˜o Preto (northeastern
region of Sa˜o Paulo State, Brazil) presented to our clinic with
painful necrotic lesions on both feet, mainly on the toes,
which had recently increased in number and size. She had a
history of headaches and seizures, an ischemic stroke five
years earlier (resulting in facial motor sequelae) and five
pregnancies, which consisted of four normal deliveries and
one abortion at 22 years of age. On examination, there were
cervical adenomegalies with bulky and coalescing lymph
nodes (the largest measuring 3 cm in diameter) and crusted
lesions on the dorsal feet and tips of the toes with purulent
exudates and interdigital maceration (Figure 1). The periph-
eral sensitivity test yielded normal results. Laboratory tests
showed hypochromic anemia with microcytosis (hemoglo-
bin: 11.0 g/dL; NR: 12.0-15.5 g/dL), increased inflammatory
activity (ESR: 30 mm/1st hour; NR: ,10 mm/1st hour;
C-reactive protein: 3.46 mg/dL; NR: up to 0.5 mg/dL;
alpha1-acid glycoprotein: 156 mg/dL; NR: 50-120 mg/dL),
increased levels of immunoglobulins (IgA: 1,070 mg/dL; NR:
134-297 mg/dl; IgG: 1,900 mg/dL; NR: 770-1,510 mg/dl;
IgM: 222 mg/dL; NR: 67-208 mg/dl), positive autoantibo-
dies (antinucleolar antibody (ANA)-positive 1:100 with
nucleolar pattern; lupus anticoagulant (PIL and dRVVT)-
positive; anticardiolipin IgG: 14.9 GPL/mL (weak positive);
NR: up to 14.0 GPL/ml; p-ANCA-positive), urinary dis-
orders (microscopic hematuria: 25-30 RBCs/field; NR: 3-
5 RBCs/field; urinary erythrocytes: 90% total dysmorphic
cells, 19% acanthocytes; NR: up 4% acanthocytes; proteinuria:
255 mg/24 h; NR: up to 150 mg/24 h), and intradermal
reaction test positive for Tb (PPD: 45 mm with necrosis).
Cervical, thoracic and abdominal computed tomographies
showed cervical adenomegaly (up to 1.8 cm in length) with
central necrosis, a left axillary 2.3-cm lymph node, and
several retroperitoneal lymph nodes (up to 0.9 cm in length).
A cranial MRI showed a cerebral infarction on the left parietal
region and lacunar infarctions in the region of capsular
nuclei. Histopathology showed the following: (1) cervical
lymph node - chronic granulomatous lymphadenitis with
caseous necrosis; (2) fifth left toe - focal granulomatous in
addition to leukocytoclastic vasculitis and direct immuno-
fluorescence (DIF) strongly positive for anti-fibrinogen serum
(3+) on capillary walls; and (3) renal biopsy - focal and
segmental sclerosis with mild focal and chronic tubulointer-
stitial damage, characterized by mesangial deposition of IgA
on DIF, which may correspond to primary IgA nephropathy
(Berger’s Disease) or Henoch-Scho¨nlein purpura (Figure 2).
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PCR with DNA that was extracted from paraffin blocks of
lymph node and skin biopsies confirmed Mycobacterium sp.
only in the lymph node (Figure 3). The final diagnosis
consisted of Tb lymphadenitis, CLV, primary IgA nephro-
pathy and APS. Ciprofloxacin (500 mg) was prescribed
twice per day for ten days, and Fluconazole (150 mg) was
prescribed once per week for eight weeks for the secondary
infection and interdigital maceration on the feet.
Thereafter, aspirin (200 mg daily) and warfarin (for antic-
oagulation) were prescribed. The patient was evaluated
by physicians in the Departments of Neurology,
Ophthalmology, Nephrology and Infectious Diseases. Tb
treatment was initiated with RIPE (rifampicin, isoniazid,
pyrazinamide and ethambutol). Because an adverse drug
reaction to pyrazinamide was observed, administration of
this medication was suspended. Because of the worsening
necrosis on her toes, the patient’s left fifth toe was
amputated with no complications. The patient finished
the Tb treatment, which was followed by weight recovery,
normalization of lymph node size, absence of new
vasculitic lesions and significant improvement of previous
skin lesions. ANA and PIL were negative, but glomerular
hematuria and proteinuria remained positive.
DISCUSSION
There are few reported cases of an association between Tb
and CLV (nine cases) and Tb and IgA nephropathy (six
cases) (2-6,13,14). Only 10% of CLV cases are attributed to
Figure 1 - Clinical presentation of a patient with cutaneous
vasculitis. The upper figures show progressive necrotic lesions on
the dorsal feet, mainly on the toes. The lower figures show the
amputation of the left fifth toe and the improvement of
vasculitic skin lesions following RIPE treatment.
Figure 2 - Histopathology of lymph node (A), skin (B) and kidney (C) biopsies. A. Chronic granulomatous lymphadenitis with caseous
necrosis without microorganisms (magnification: 20x and 40x) B. Leukocytoclastic and focal granulomatous vasculitis (objectives: 20x
and 40x) C. Renal biopsy contained 13 glomeruli, 12 normal and one with a focal segmental lesion. DIF showed diffuse and global
mesangial deposits of IgA (objective: 40x).
Figure 3 - 2% agarose gel. PCR was performed with specific
primers for Mycobacterium sp. (17), whose amplicon is 383 bp.
Columns: 1 and 7, 100-bp marker; 2, negative control (without
DNA); 3, paraffin biopsy of skin vasculitis; 4, paraffin sample of a
cervical lymph node; 5, culture of M. avium complex; and 6,
culture of M. tuberculosis. PCR was positive for M. tuberculosis
culture and the cervical lymph node (site of infection) and
negative for the skin (hypersensitivity vasculitis).
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drugs and infections, and 61% are considered idiopathic
cases. Considering the existence of circulating immune
complexes in pulmonary Tb and the relationship between
immune complex levels and disease activity, the damage
mechanism that has been proposed for this type of
vasculitis is the deposition of immune complexes that are
formed by antibodies against antigens of the bacterium on
the vascular wall rather than direct aggression by the
bacterium (8,9). Up to 56% of Tb patients have circulating
immune complexes, and there is evidence of increased
immunoglobulin levels in these patients, mainly IgA and
IgG, as was observed in our patient. These immunoglobu-
lins are produced against the A-60 antigen of the
mycobacterium, leading to the formation of immune
complexes (11).
Another differential diagnosis is the onset of vasculitis
following rifampicin therapy, as demonstrated in some case
reports, where CLV occurred due to this medication (7).
However, our patient had skin lesions before using this
drug. In cases of Tb-related vasculitis, skin lesions improve
with RIPE treatment alone; no specific anti-inflammatory
therapy is required (2-7,10,15).
In 1985, Cohen and Rosenstein (12) described a case of an
association between Tb and IgA nephropathy in which renal
involvement improved after Tb treatment. In this case, HSP
needed to be considered. HSP is a type of systemic vasculitis
that is more common in children, and both renal involve-
ment, defined as IgA nephropathy, and palpable purpura
appear in 50% of cases (6,13,14). Some specialists defend the
theory that Berger’s disease is a restricted form of HSP, and
there have been five reported cases of HSP associated with
Tb. However, our patient presented with CLV with anti-
fibrinogen, not IgA, deposition in the capillary walls, which
rules out a diagnosis of HSP.
In addition, PCR with primers specific to Mycobacterium
(17) was performed in cervical lymph node and skin
samples, which confirmed the etiology of Mycobacterium
sp. in the lymph node sample but not in the skin sample.
The DNA that was extracted from the paraffin skin sample
was amplified with keratin primers, confirming its integrity
(data not shown). These results strongly suggest a hyper-
sensitivity form of CLV.
None of the case reports of Tb associated with CLV or Tb
associated with IgA nephropathy in the literature included
descriptions of positive autoantibodies. In our patient,
ANA, p-ANCA and lupus anticoagulant (PIL and dRVVT)
tests were positive, and there was a prior medical history of
ischemic stroke (confirmed by MRI). These findings
reinforce the diagnosis of an autoimmune disease and lead
us to a diagnosis of APS secondary to Tb.
The production of anti-phospholipid antibodies (aPLs)
could have either an autoimmune or infectious origin. The
latter origin does not involve anti-b2-glycoprotein I (anti-
b2GPI) activity and usually does not cause thrombosis.
However, there have been recently described cases of
lepromatous leprosy patients with genetically determined
anti-b2GPI activity followed by thrombosis (18). By indu-
cing a specific cellular immune response and secondary
antibody production (as noted by the strong positive PPD
and increased immunoglobulin levels), tuberculosis stimu-
lates the production of autoantibodies (including aPLs) and
procoagulant factors, such as plasma fibrinogen (factor I),
factor VIII and D-dimers. Thus, M. tuberculosis can be
considered an etiologic factor in aPL production and the
triggering of APS (19).
In the literature, there is a single report of concomitant
CLV, Sweet syndrome, cutaneous polyarteritis nodosa and
cervical adenopathy caused by M. fortuitum (20). The
association of Tb, focal granulomatous, CLV and IgA
nephropathy in a single patient has not been reported. This
case is complex, demonstrating rare manifestations of an
endemic disease in Brazil, and serves as a warning to
dermatologists to be cautious in the differential diagnosis
of patients with vasculitic presentations.
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